Charles-Lim Capital Ltd — 13F Portfolio

Charles-Lim Capital Ltd is a Hong Kong-based alternative investment manager specializing in Asia-focused long/short equity strategies with global market participation. The firm files 13F reports with the SEC under CIK #0001634255, maintaining a multi-year disclosure history that provides meaningful visibility into the U.S.-listed component of its broader investment activities spanning Asian and global equity markets. The firm's hyphenated name—Charles-Lim—suggests co-founder heritage, likely reflecting the partnership between principals who established the investment practice. This naming convention signals personal accountability and the collaborative leadership structure characteristic of founder-led hedge funds where principal alignment with investor outcomes defines the organizational culture. Operating from Hong Kong positions Charles-Lim Capital within one of Asia's premier financial centers, providing direct access to Chinese markets, established relationships with Asian corporate management teams, and institutional infrastructure supporting sophisticated investment strategies. Hong Kong's regulatory framework under the Securities and Futures Commission (SFC) establishes operational standards recognized by global institutional investors, while the geographic positioning enables real-time engagement with Asian markets across time zones. The extended 13F filing history under CIK #0001634255, spanning nearly a decade, provides substantial longitudinal data for analyzing the firm's U.S. market participation alongside its core Asian investment activities. This disclosure record encompasses multiple Asian market cycles, Chinese regulatory developments, and global macro events affecting cross-border investment dynamics.

Charles-Lim Capital employs a fundamentally-driven, long/short equity strategy with primary emphasis on Asia-Pacific markets while maintaining meaningful participation in U.S. and global equities. The firm's approach combines deep regional expertise with the flexibility to pursue opportunities across geographies, seeking alpha through superior company analysis and dynamic portfolio construction. The investment process emphasizes intensive fundamental research—detailed analysis of business models, competitive positioning, management quality, and growth trajectories—applied across Asian and global markets. The Hong Kong base provides natural advantages for Asian investment sourcing, including cultural understanding, language capabilities, and relationship networks that enable differentiated research access unavailable to foreign competitors. The long/short structure enables expression of both positive and negative investment views, allowing the firm to profit from overvalued or deteriorating situations through short positions while maintaining long exposure to compelling opportunities. This approach provides hedging capabilities and alpha generation potential beyond what long-only strategies can achieve. The Sector Allocation History observable through 13F filings reveals U.S. positioning patterns likely correlated with the firm's broader Asia-Pacific investment themes. The Top 10 Holdings Concentration provides insight into conviction levels among U.S.-listed positions, which may include American Depositary Receipts (ADRs) of Asian companies alongside U.S. businesses with significant Asian operations. The concentration dynamics reflect the conviction-based approach characteristic of hedge fund strategies. Turnover characteristics trend toward moderate to higher levels, reflecting the dynamic nature of long/short investing where both longs and shorts require active management as fundamental developments and price movements alter risk-reward profiles.

Charles-Lim Capital Ltd presents a multi-year Historical Track Record visible through SEC filings under CIK #0001634255, providing meaningful insight into the U.S.-listed component of the firm's Asia-focused long/short equity strategy across varying market environments. The Annualized Return (CAGR) derived from disclosed holdings captures performance of U.S.-listed positions but necessarily excludes locally-listed Asian securities that likely constitute substantial portfolio allocation. Analysts should recognize that 13F disclosures represent a partial view of overall investment activities, with significant non-U.S. exposure remaining invisible in American regulatory filings. The Sharpe Ratio provides directional insight into risk-adjusted outcomes, though the metric captures only the disclosed U.S.-listed portfolio segment. The Asia focus and long/short approach create expectations for alpha generation through regional expertise translating into differentiated fundamental research. The 13F Portfolio Composition across multiple years illuminates positioning evolution through changing Asian market dynamics. The extended filing period encompasses significant regime shifts for Asian investments—regulatory developments in China, Hong Kong political transitions, pandemic impacts, and U.S.-China tensions—providing insight into how the firm navigated these Asia-specific challenges. Key analytical dimensions for Charles-Lim Capital include sector concentration within Asian themes, ADR exposure and associated regulatory risks, and position sizing evolution reflecting conviction dynamics. The Hong Kong heritage establishes expectations for Asia expertise that should manifest in differentiated investment insights. Given Charles-Lim Capital's Hong Kong base, decade-long 13F history, and Asia-focused investment mandate, how has the Sector Allocation History evolved through recent regulatory and geopolitical challenges affecting Asian investments—particularly Chinese ADRs and technology sectors—and what current U.S. market positioning signals the firm's view on cross-border investment dynamics in the evolving U.S.-China relationship?

Charles-Lim Capital's Asia-focused long/short strategy produces a distinctive risk profile characterized by Asian market exposure, currency dynamics, and regulatory considerations specific to cross-border investing. The long/short structure provides hedging capabilities that can moderate net market exposure, though positioning varies based on opportunity assessment and conviction levels. The Volatility Profile for Asia-focused strategies typically exceeds developed market alternatives due to emerging market dynamics, currency fluctuations, and the higher beta characteristics of Asian growth sectors. Chinese ADRs and Hong Kong-listed companies—likely prominent in the broader portfolio—have demonstrated elevated volatility driven by regulatory uncertainty, geopolitical tensions, and sector-specific dynamics affecting Asian technology and consumer companies. Max Drawdown Depth analysis across Charles-Lim's multi-year 13F history provides insight into downside behavior during Asia-specific and global market dislocations. The extended filing record encompasses challenging periods for Asian investments including Chinese regulatory crackdowns, U.S.-China trade tensions, Hong Kong political developments, and the COVID-19 pandemic originating in Asia—providing multiple stress tests for evaluating portfolio resilience. The Hong Kong base introduces geopolitical considerations that have intensified in recent years. Regulatory developments affecting Hong Kong's financial status, tensions between the U.S. and China affecting ADR listings, and cross-border capital flow dynamics create risk factors beyond traditional market exposure. The Downside Capture Ratio derived from disclosed U.S.-listed holdings provides partial insight into risk management, though the broader portfolio including locally-listed Asian positions remains invisible in 13F filings.